Group structure
7 companies in 7 countries
Loading your pageโฆ
Loading your pageโฆ
7 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 99
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Aglurab 1000 mg filmom obloลพene tabletefilmom obloลพena tableta | Metformin | Croatia | Marketed | 2015 |
| Aglurab 500 mg filmom obloลพene tabletefilmom obloลพena tableta | Metformin | Croatia | Marketed | 2015 |
| Aglurab 850 mg filmom obloลพene tabletefilmom obloลพena tableta | Metformin | Croatia | Marketed | 2015 |
| Albiomin 20%200g/L ยท rastvor za infuziju | Albumin, Humani | Serbia | Authorised | 2024 |
| Alvescoยฎ160mcg/doza ยท rastvor za inhalaciju pod pritiskom | Ciclesonide | Serbia | Authorised | 2021 |
| Alvescoยฎ80mcg/doza ยท rastvor za inhalaciju pod pritiskom | Ciclesonide | Serbia | Authorised | 2021 |
| Avonexยฎ30mcg/0.5mL ยท rastvor za injekciju u napunjenom injekcionom ลกpricu | Interferon beta-1a | Serbia | Authorised | 2025 |
| Avonexยฎ30mcg/0.5mL ยท rastvor za injekciju u napunjenom injekcionom ลกpricu | Interferon beta-1a | Serbia | Authorised | 2025 |
| Cosoptยฎ20mg/mL+5mg/mL ยท kapi za oฤi, rastvor | Dorzolamide, Timolol | Serbia | Authorised | 2024 |
| Ducressaยฎ1mg/mL+5mg/mL ยท kapi za oฤi, rastvor | Dexamethasone, Levofloxacin | Serbia | Authorised | 2023 |
| GELODOL CREMA9 g ยท Crema | Aceite rosmarinus officinalis | Spain | Marketed | 2016 |
| Gelomyrtol forte 300 mg meke ลพeluฤanootporne kapsuleลพeluฤanootporna kapsula, meka | Destilat mjeลกavine proฤiลกฤenih eteriฤnih ulja eukaliptusa, slatke naranฤe, limuna i mirte | Croatia | Marketed | 2017 |
| Haemoctin SDH500i.j./5mL ยท praลกak i rastvaraฤ za rastvor za injekciju | Antihemophilic factor | Serbia | Authorised | 2024 |
| Haemoctin SDH1000i.j./5mL ยท praลกak i rastvaraฤ za rastvor za injekciju | Antihemophilic factor | Serbia | Authorised | 2024 |
| Haemonine 1000100i.j./mL ยท praลกak i rastvaraฤ za rastvor za injekciju | Coagulation factor ix | Serbia | Authorised | 2021 |
| Haemonine 500100i.j./mL ยท praลกak i rastvaraฤ za rastvor za injekciju | Coagulation factor ix | Serbia | Authorised | 2021 |
| Hepatect CP50i.j./mL ยท rastvor za infuziju | Hepatitis b immunoglobulin | Serbia | Authorised | 2021 |
| Hepatect CP50i.j./mL ยท rastvor za infuziju | Hepatitis b immunoglobulin | Serbia | Authorised | 2021 |
| Hepatect CP50i.j./mL ยท rastvor za infuziju | Hepatitis b immunoglobulin | Serbia | Authorised | 2021 |
| Ikervisยฎ1mg/mL ยท kapi za oฤi, emulzija | Ciclosporin | Serbia | Authorised | 2025 |
| Intratect100mg/mL ยท rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2023 |
| Intratect100mg/mL ยท rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2023 |
| Intratect50mg/mL ยท rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2025 |
| Intratect50mg/mL ยท rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2025 |
| Intratect100mg/mL ยท rastvor za infuziju | Humani normalni imunoglobulin za intravensku upotrebu | Serbia | Authorised | 2023 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Serbia | 67 | 65 | 2 | CompaniesAll medicines |
| Saudi Arabia | 22 | 22 | 0 | CompaniesAll medicines |
| Croatia | 8 | 8 | 0 | CompaniesAll medicines |
| Spain | 2 | 1 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.